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The production of antibodies  against antigens  of sheep  erythrocytes and bovine 
serum albumin depends on the cooperation of at least two major cell  types in mice 
(1--4).  Bone marrow contains the precursors of immunocytes which  are induced to 
differentiate and mature by cells of thymic origin. Little is known about the mechanism 
of this induction process, except that thymocytes are not ancestral to immunocytes 
(2, 5-8). They are, however, the cells that react with, or respond to, antigen to initiate 
events leading to antibody formation (5, 9). For this reason, the relevant thymocytes 
have  been  designated antigen-reactive cells  (5).  Although the way in which ARC  1 
interact with immunocyte precursors is not understood, it has been established  that 
ARC do not specify the molecular class of antibodies to be produced by marrow-derived 
ceils (10, 11). In cell transfer experiments the number of ARC available for interaction 
with marrow ceils  was limited to 1 or a  few. Under such conditions, interaction of 
individual ARC (or of their descendent cells) occurred with several marrow precursors 
of plaque-forming ceils (P-PFC) without regard to the class of antibody to be produced 
by the latter.  In other words, under the influence of antigen,  each individual  ARC 
induced  the  formation of more  than  one antigen-sensitive  unit  (ASU).  These  are 
functional units committed to the production of immunocytes secreting antibody of a 
single molecular class and specificity (12-15). Accordingly, among the ASU resulting 
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from exposure of 1 ARC to marrow cells and sheep erythrocytes, some generated direct 
PFC and others indirect PFC (10). 
Thymic ARC might be capable of interacting with more than  one P-PFC, 
either simultaneously or in rapid  succession (10). However, it is also possible 
that ARC proliferate upon exposure to antigen  and  that the descendant  cells 
interact  with  marrow P-PFC.  If each progeny  cell  were  to  interact  with  1 
P-PFC,  formation of more than  1 ASU/ARC  would still  be expected.  These 
possibilities can be subjected to verification by two-step experiments in which 1 
or a  few ARC are first exposed to antigen in the absence of marrow ceils,  and 
several days later allowed to interact with marrow cells and with antigen again. 
One-step experiments are those in which marrow and thymus ceils are mixed and 
exposed to antigen at the same time. If thymic ARC were the ceils that interact 
with marrow P-PFC  without having to undergo proliferation,  the number of 
ASU formed per ARC should be equal in one-step and two-step experiments. 
However, were ARC to proliferate under the influence of antigen before inter- 
action with P-PFC,  then the number of ASU per initial  thymic ARC should 
increase  in  two-step  experiments,  assuming  that  under  these  conditions  the 
proliferative  potential  of ARC  is  fully realized.  The  results  reported  in  this 
paper support the second possibility. In the course of establishing the require- 
ments for antigen in two-step experiments,  it was also found that PFC produc- 
tion is dependent on the presence of SRBC at two critical stages of the immune 
response: first, when thymic ARC are stimulated,  and second, when ARC prog- 
eny and marrow cells are mixed for interaction. 
Materials and Methods 
M/c¢.--(C3H/I:Ie X  C57BL/I-Ia)F1 and (C57BL/6 X DBA/2Cr)FI females, 9-12 wk old, 
were used as donors and recipients in syngeneie eell transfers.  The abbreviated  designations 
for the two hybrid strains are C3BF1 and BDF1, respectively. 
Irradiation.--Miee to be grafted with bemopoietic ceils were exposed to 825-850 R of total 
body X-radiation  as described elsewhere (12). 
Cell Suspensions and Transplantation.--Nudeated bone marrow and thymus cells of normal 
mice, and spleen cells of irradiated-reconstituted  mice suspended in Eagle's  medium, were 
counted  and injected into a lateral  tail  vein of irradiated  syngeneie mice as previously  de- 
scribed (16). 
Immunisation.--Either  at the time of cell transplantation  or 18 hr later,  each irradiated 
mouse was injected intravenously  with 5 X  10  s washed sheep erythroeytes  (SRBC) in 0.5 
ml of Eagle's medium. Fresh defibrinated sheep blood was obtained every 2nd wk from Grand 
Island Biological Co., Grand Island, N. ¥. 
Assays for Plaque-Forming Cd/s.--Direct and indirect PFC were enumerated in spleen cell 
suspensions of test recipient mice by the agar gel method  of Jerne,  as previously described 
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Statistical Methods.--Limiting  dilution assays were performed to estimate the frequencies 
of ARC in thymus cell suspensions of normal donors and in spleen cell suspensions of irradiated 
donor mice  reconstituted with thymocytes and  SRBC.  The  experimental design for such 
limiting dilution assays and the statistical analysis of results have been described elsewhere 
(10,  12). 
TABLE  I 
Production of PFC in Irradiated C3BFz Mice Injected wRh l0  T  Marrow Ceils, SRBC, and 
Retransplanted Thymocytes Exposed in Vivo to SRBC* 
Thymocyte residence 
m primary recipient 
Cell mixture residence 
in test recipient 
Fraction of positive spleens in test recipients and 
mean No. of PFC per positive spleen -4- ss~ 
Direct PFC  Indirect PFC 
d~ys  days 
3  7  5/7  0/7 
245  .4-  81 
5  7  20/21  12/22 
985  4-  478  320  4-  48 
s  10  6/6  6/6 
735  .4-  208  490  .4-  91 
5  12  415  4/5 
335  .4-  72  750  .4-  215 
6  7  5/5  4/5 
855  -4- 210  390  ~  116 
7  7  4/5  2/5 
345  +  61  290  -t-  145 
7  s  3/3  3/3 
1380  +  333  868  -t-  390 
7  10  3/3  2/3 
410  4-  91  240  -4-  10 
* l0  s thymocytes mixed with SRBC injected into mice exposed to 850 R. All cells lodging 
in one recipient spleen were recovered 3-7 days later and retransplanted with marrow cells 
and SRBC into one irradiated test recipient. 
Spleens were regarded as positive if they contained more than 100 direct or 50 indirect 
PFC  (11, 16). 
RESULTS 
Reaction of Thymocytes with SRBC Prior to Interaction  with Marrow Cdls.~ 
It has been demonstrated by Mitchell and Miller (5)  that thymic ARC  can react with 
SRBC in the absence of viable marrow cells (first step) and that they maintain for at least 
7 days the ability to interact with marrow precursors of direct PFC (second step). The immune 
response to SRBC was thereby presumably dissected into two discrete sequential steps, thus 
permitting analysis of the effects of antigen on ARC, on the one hand, and of the requirements 
for effective marrow-thymus interaction, on the other.  Data are not available on indirect 
PFC production by marrow-thymus cell mixtures in two-step experiments, or on the necessary 
duration of the first step. Therefore, 56 irradiated mice were injected with l0  s  thymocytes 
mixed with SRBC. These mice were used 3, 5, 6, and 7 days later as donors of thymus-derived 1246  PROLIFERATION  OF THSC~IC ARC 
cells. The thymocytes lodging in the spleens of one primary recipient were suspended and 
mixed with 10  7 marrow cells and SRBC. This mixture was injected into one irradiated  test 
mouse to produce anti-sheep PFC. Plaque assays were made 7-12 days later on test recipient 
spleens. 
The results are presented in Table I. 
Mter 3 days in primary recipients, thymocytes recovered from the spleen were 
relatively ineffective for interaction with P-PFC. Test recipients contained few 
direct  PFC  and no indirect  PFC  in their  spleens.  After 5-7  days in primary 
recipients,  the  thymocytes recovered were capable of inducing direct  and  in- 
direct PFC production by marrow cells in almost every test recipient, provided 
that  the plaque  assays were done 8  days after retransplantation  or later.  For 
this reason, retransplantation of thymus-derived cells was done in all subsequent 
two-step experiments on the fifth day, and plaque assays on the eighth day, after 
retransplantation. 
Antigen Requirements  for Marrow-Thymus Interaction in Two-Step Experi- 
ments.--In the preceding  experiment  SRBC  were given twice: at  the time  of 
thymocyte  transplantation  and  at  the  time  of  thymocyte  retransplantation 
with marrow cells.  Mitchell and Miller have shown that immunocytes are not 
produced  if SRBC  have been  omitted  or substituted  with  non-cross-reacting 
erythrocytes in thefirst step (5). However, it was not reported whether SRBC 
are necessary during  the first  and second steps,  or whether  they could be  re- 
placed  in  the  second step  by non--cross-reacting erythrocytes.  Also,  it  is  not 
known whether PFC  could be produced in a  reversed two-step experiment  in 
which marrow cells are transplanted first with antigen, and then retransplanted 
with thymocytes from normal donors and SRBC. 
Groups of irradiated  mice were injected with either  10  a thymocytes or I0  s bone marrow 
cells, with or without SRBC. After 5 days in irradiated  host mice, cells that lodged in one 
spleen were retransplanted  into one test  recipient  together  with either  10  ~ marrow cells, or 
10  a thymocytes,  respectively, with or without SRBC. In a few experiments, spleen cells of 
one marrow-injected primary recipient were mixed for retransplantation  with spleen cells of 
one thymus-injected  mouse. Finally, SRBC were replaced by burro or rat erythrocytes  in the 
second step of an experiment in which thymus-derived cells were retransplanted  with marrow. 
Negative  controls were set up by omitting  thymocytes or SRBC  (but not both) in primary 
recipients.  Positive  controls were set up by injecting  thymocytes and SRBC into primary 
recipients, and by retransplanting  thymus-derived cells with marrow and SRBC. 
The 8-day production of direct PFC by the different cell mixtures is reported 
in Table II. 
The positive and negative control groups that were set up (Nos. 1-5 of Table 
II) confirmed the results of Mitchell and Miller (5). To obtain PFC in two-step 
experiments, thyrnocytes had to be injected with SRBC into primary recipients, 
and  retransplanted  with  marrow and  SRBC  into  test  recipients.  Our  experi- G. M. SHEARER AND G. CUDKOWICZ  1247 
mental groups indicated, furthermore, that SRBC were necessary in both the 
first and second steps (Nos. 6-9 of Table II). Retransplanted thymocytes  mixed 
with marrow cells from normal donors or with retransplanted marrow cells failed 
to generate PFC if SRBC were omitted at the time of cell mixing. It is possible 
TABLE  II 
Antigen  Requirements for Anti-Sheep  PFC Produstion by Marrow and Thymus cells in 
Two-Step Exp~im~ts 
Cells injected into  Mean No. of  direct PFC per  Fractionof  positive  Group  spleen of test  spleens§ 
Primary recipients*  Secondary reciplents:~  recipients =h sE 
I  SRBC  SPI[+ BM  +  SRBC  46 ±  20  1/6 
2  TY  SPTy +  BM  +  SRBC  35 4- 18  1/9 
3  TY +  SRBC  SPTY +  BM  +  SRBC  760 4- 97  31/33 
4  TY + SRBC (2X)  SPTy +  BM  +  SRBC  585 4- 161  9/9 
5  TY -]- SRBC  SPTy + BM + SRBC (2X)  1320  "4- 210  II/II 
6  TY +  SRBC  SPTy +  BM  28 "4- 8  0/11 
7  TY -}-  SRBC (2X)  SPTy +  BM  29 4- 15  1/14 
8  TY  -~  SRBC;  SPTy -Jc SPBM "~- SRBC  577  q-  57  5/5 
BM  +  SRBC 
9  TY  +  SRBC;  SPTy  +  SPBM  87  4-  22  1/4 
BM  +  SRBC 
10  BM  n  u  SRBC  SPBM  -F  TY  q-  SRBC  358  q-  150  8/11 
11  BM  SPBM  +  TY  +  SRBC  820  4.  264  6/6 
12  BM  +  SRBC  SPBM  +  TY  35  4-  18  0/6 
13  TY  +  SRBC  SPTy  +  BM  +  BRBC  64  -4-  19  4/22 
14  TY  -~-  SRBC  SPTy  q-  BM  q-  RRBC  15  4.  3  0/13 
* Primary recipients were irradiated and injected with either 10 s thymocytes or l0  s bone 
marrow cells, with or without SRBC. 5 days later the spleen cells of one mouse were retrans- 
planted into one test recipient. 
Test recipients were  irradiated  and injected  with one of  the following cell mixtures: 
spleen cells of one primary recipient and  10 7 marrow cells with or without antigen (groups 
1-7, 13, and 14); one primary recipient spleen and l0  s thymocytes with or without antigen 
(groups  10-12);  cells of  two  different primary recipient spleens with or  without  antigen 
(groups 8 and 9). 
§ Containing more than 100 direct PFC. 
[[ Abbreviations: BM, bone marrow cells; SP,  SPTy, SPBM, spleen cells from a primary 
recipient injected with SRBC, thymocytes, or marrow cells, respectively; TY, thymocytes. 
that two-step experiments require two antigen injections at critical times, e.g. at 
the time of initial stimulation of ARC and at the time of interaction between 
thymic inducer cells and marrow P-PFC. To verify this possibility, groups of 
mice were injected twice with SRBC, but not at the time of cell mixing (Nos. 
7 and 9 of Table II); in neither instance were PFC produced. Thus, antigen was 
required first for ARC stimulation and again at the time of cell mixing and re- 1248  PROLIFERATION  OF THYMIC ARC 
transplantation.  The second antigen  injection could have mediated  the inter- 
action between cells or stimulated marrow cells before, after, or during the inter- 
action. It was of interest,  therefore, to establish whether incubation of marrow 
cells with SRBC resulted,  as in the case of thymocytes, in specific activation. 
Marrow cells that were injected into primary recipients with or without SRBC 
were equally competent on retransplantation to interact with thymocytes (Nos. 
10-12 of Table II). Hence, SRBC had no detectable effect on marrow cells. As 
before, antigen was required in the second step of the experiment.  In this case, 
the  second  injection  of antigen  initiated  and  completed  the  response;  i.e.  it 
stimulated  ARC  and  either  mediated  cell  interactions  or stimulated  marrow 
cells. 
The  requirement  for the  second injection  of SRBC  could have been  non- 
specific.  If so,  other xenogeneic  erythrocytes might  substitute  effectively for 
SRBC.  However,  anti-sheep PFC were not formed when burro or rat erythro- 
cytes were injected  with marrow and thymocytes preexposed to SRBC  (Nos. 
13 and 14 of Table I_I). Thus, whatever is the nature of the events following the 
second antigen injection, the triggering of the second step of the PFC response 
appears to be as antigen-specific as the initial reaction of thymocytes. 
In summary, these experiments have shown that thymic ARC are the mini- 
real requirements for initiation of the antibody response to SRBC, since activa- 
tion of ARC occurred in the absence of viable marrow cells,  and activation of 
marrow cells did not occur in the absence of viable thymocytes. At least one 
other subsequent event in the PFC response is dependent on the same antigen 
complex used for initiation, since the response did not occur unless SRBC were 
added  to SRBC-activated  thymocytes at  the  time  of retransplantation  with 
marrow. 
Frequency of ARC-Derived Inducer Cells in C3BF1 Mice.-- 
Following transplantation  of 107 thymoc3rtes and SRBC, an average of 1 ARC lodges in 
the spleens of irradiated  recipient mice (10). In an attempt to establish whether ARC pro- 
lfferated after exp~ure to SRBC, we injected graded numbers of thymocytes with antigen 
into irradiated  mice. 5 days later,  each primary recipient spleen was retransplanted  into one 
test recipient with 107 marrow cells and SRBC to assess its content of ARC-derived inducer 
cells by formation  of direct  and indirect  PFC. The number of marrow cells was chosen to 
provide adequate numbers of PFC precursors (11). The spleens of the groups of mice injected 
with 107 or fewer thymocytes received either 1 or a limited number of ARC, or none (Poisson 
distribution).  Had ARC proliferated in such spleens, enough new cells could have arisen to 
provide, on retrausplantation,  test recipient spleens with at least 1 inducer cell. Had ARC not 
proliferated  extensively, the probability  that small numbers  of retransplanted  ARC could 
reach test recipient spleens would be very low, since through dilution only 4--15% of immuno- 
competent  cells injected into.the blood stream lodge in spleens (17-19). Hence, ff each pri- 
mary recipient spleen (cont~inins 1 or 2 ARC) is to repopulate test spleens with inducer cells, 
the dilution must be compensated for by a 10-100-fold increase in the number of inducer cells. G.  M.  SHEARER AND G.  CUDKOWICZ  1249 
All negative primary spleens (containing no ARC) should yield negative test spleens on re- 
transplantation. 
The results are presented in Table HI and Fig. 1. 
As the number of thymocytes grafted into primary recipients increased from 
1.2 to 25 ×  106, the proportion of mice with spleens positive for ARC-derived 
cells increased. 22 of 24 spleens that were positive for inducer cells yielded both 
direct and indirect PFC on retransplantation  with marrow. Most test spleens 
TABLE HI 
Percentage of Posi~ire Spleens in C3BFI  Test Red,lent Mice after Infusion of 10  7 Marrow 
Cells, 5 X  lO  s SRBC, and Rdransplanted  Thym~ytes* 
No. of thymo-  cytes to i)rl-  Fraction  of pos- Percentage  of pod-  Mean  No. of PFC  Pooled  prgbabillty of 
mary recipients  itive spleens~  tive spleens~  per positive test  positive ~leens per lOe  (X 10  e)  spleen -4- sz  transplants!  thymocytee 
Dired PFC 
1.2  2/10  20.0  273  4-  138 
2.5  2/8  25.0  380  -t- 220 
5.0  3/8  37.5  290 -4-  75 
10.0  3/5  60.0  625  -t-  194 
12.5  10/11  91.0  670  -~  169 
25.0  7/7  100.0  1360 d= 245 
Indirect PFC 
1.2  2/10  20.0  187  -t-  87 
2.5  1/8  12.5  470 
5.0  2/8  25.0  277  ~  112 
10.0  3/5  60.0  453  -4- 225 
12.5  7/8  87.5  350  -t-  135 
25.0  7/7  100.0  575  4-  110 
0.12 
(0.09-~0.16)§ 
* Graded numbers of thymocytes mixed with SRBC to primary recipients. All cells lodging 
in one recipient spleen were retransplanted  5 days later into one test recipient. 
More than 100 direct PFC or 50 indirect PFC (10). 
§ 95% confidence intervals in parentheses. 
were therefore either positive or negative for both types of PFC. It follows that 
the relation between the percentage of positive test spleens and the number of 
thymocytes grafted into primary recipients did not vary significantly for direct 
and indirect PFC. This confirms previous results and the conclusion that ARC 
lack specialization for antibody class (10). For a  given number of thymocytes, 
the proportion of positive spleens was similar in this two-step and in a preceding 
one-step limiting dilution assay (10). The probability value that 10  ~ thymocytes 
would yield primary spleens positive for ARC was 1.0 (10). The corresponding 
value for positive test spleens on retransplantation was 1.2. The curves of Fig. 1, 1250  PROLLPERATION OF  TttYMIC ARC 
relating  inoculum  size  to  the  expected  frequencies  of positive  spleens,  were 
plotted using the Poisson model. The observed frequencies in one-step and two- 
step experiments  fit the model, and the values are not significantly different. 
This result implies that negative test spleens in the two-step experiment were 
due entirely to lack of ARC in the retransplanted  primary spleens.  It also im- 
plies that all positive prima~3r spleens yielded positive test  spleens,  in spite of 
the  10-100-fold  dilution  of ARC  on  retransplantation.  Hence,  the  results 
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Fzo. 1.  Percentage of spleens positive for direct (A, O) and indirect (0) PFC after injec- 
tion of irradiated  test mice with marrow cells, SRBC, and graded numbers  of thymocytes 
(one-step  experiments)  or thymus-derived  ceils (two-step  experiments).  The  numbers  of 
spleens assayed are given in Table HI and IV. Symbols indicate observed percentages, and 
curves expected percentages according to the Poisson model The C3BF~ two-step curve was 
fitted to the pooled percentages of positive spleens for direct and indirect PFC, since prob- 
ability values were overlapping. The C3BF1 one-step curve was taken from reference 10. The 
numbers of transplanted  thymocytes for 63% positive spleens contain an average of 1 detect- 
able ARC and are indicated by dotted lines. 
strongly suggest that under the influence of SRBC, ARC proliferated during the 
5 days between transplantations. 
Frequency of Thymic ARC in BDF1 Mice.-- 
Quantitative  variations  of the plaque  response to SRBC have been described in several 
swains of mice (20-22). Conceivably, the results obtaiued  with C3BFI hybrids  could have 
reflected the particular  immunocompetence determined by the genomes of C3H and C57BL 
mice. It was desirable, therefore, to study ARC in at least another hybrid mouse. A limiting 
dilution assay:for thymic ARC was made in BDFI mice using the one-step design (10). Direct 
PFC were enumerated in the spleens of irradiated  recipients 8--9 days after transplantation  of 
graded numbers of thymocytes mixed with 2 X  107 marrow cells. 
Results are shown in Table IV and Fig. 1. G.  M.  SHEARER  AND  G.  CUDKOWICZ  1251 
As in previous assays of this type, the percentage of recipient spleens receiving 
1 or more ARC, and consequently containing significant numbers of PFC, de- 
pended on the number of thymocytes grafted. The relationship between these 
two variables was predicted by the Poisson model. It was possible, therefore, to 
estimate the number of ARC per unit number of thymocytes (10). As the fre- 
quencies of positive spleens increased in recipients of the larger inocula of thy- 
mocytes, the mean number of PFC per positive spleen did not increase in pro- 
portion. This suggested that once spleens contained 1 or a  few ARC,  nearly 
equal numbers of ASU were formed, provided that adequate numbers of P-PFC 
were available. The interpretation was supported by the fact that P-PFC were 
TABLE IV 
Percentage of Positive BDF1 Recipient Spleens after Infusion of 2 X  10  7 Marrow Cells, 
5 X  10 s SRBC, and Graded Numbers of Thymocytes 
No. of thymocytes  Fraction of  Percentage of  Mean No. of direct  Probability of positive 
positive spleens*  spleen  4- sz  thymocytee  tran&p~n~ed  positives spleens  PFC per positive  spleen per lOe transplanted 
One-Step Experiments 
0.62  3/8  37.5  342  4- 24 
1.25  6/16  37.5  450 -4- 60 
2.50  7/15  46.6  518 4- 235 
5.00  14/17  82.4  515 -4- 116 
I0.00  I0/I0  I00.0  857  4-  199 
T~oo-Step Experiments 
8.00§  31/35  88.6  700 -4-- 102 
0.33 
(0.23--0.47):1: 
* More than 100 direct PFC/spleen. One-half  of all spleen cells were plated. 
~; 95% confidence  intervals in parentheses.  * 
§ To primary recipients. Cells lodging in one spleen were retransplanted 5 days later with 
marrow cells into one test recipient. 
present in excess numbers by design, and that under the proper conditions (e.g. 
low ARC/P-PFC  ratio) 1 ARC induced more than 1 marrow cell to generate 
PFC (10). The only difference noted between thymic ARC of BDF1 and C3BFx 
mice was quantitative: I  ARC/3  ~  I  X  I06 BDFa thymocytes, and I  ARC/ 
I0 -4- 2 X  106 C3BFI thymocytes (I0). Since the number of nucleated cells per 
organ was similar in the two strains, the thymus of BDFt mice contained 3 times 
as many ARC as the thymus of C3BFI mice. 
To verify that ARC also proliferated in BDFt mice under the influence of 
antigen, 8  X  10  s thymocytes were grafted with SRBC into irradiated BDFt 
hosts. This provided each spleen with an average of 2-3 ARC. 5 days later, cells 
of one spleen were mixed with 107 marrow cells and retransplanted into one test 
recipient with SRBC for PFC production. As was the case in C3BF1 mice, the 
percentage of PFC  response in the two-step experiment was  similar to that 
found in one-step experiments (Table IV). 1252  PROLIFERATION  01;'  THYMIC  ARC 
Frequency of ARC-Derived Imiu~cr Cells in BDFt Mice.-- 
In  the preceding two-step experiments,  whole spleens of irradiated  mice injected with 
thymocytes and SRBC were individually retranspianted into test recipients. All ARC progeny 
cells in each primary spleen were given to one test recipient. This was done to increase the 
probability of recovering such cells in spleens of secondary hosts despite cell dilution. Since 
the results dearly indicated antigen-dependent expansion of inducer ceils, it was of interest to 
estimate the magnitude of this expansion and to verify that it was due to proliferation. By 
retransplanting graded fractions of primary spleens containing the progeny of 1 or a few ARC, 
TABLE V 
Percentage  of Posi~e Spleens in BDF1 Tes~  Recipient Mice after Infusion of 1.5 X  10  7 Marro~o 
Cells, 5 X  lO  s SRBC, and Re~ransplanted Thymocytes*, ~, 
Portion of prL  Probability of positive test  mary spleen re-  Fraction of pos-  Percentage of  Mean No. of direct PFC  spleens per 1/100th of re- 
transplanted  itive spleens~  positive spleens~  per positive spleen .4- sz  transplanted primary spleens 
with marrow 
Re~ransplantation 4 Days after SRBC 
1/128  2/12  18.2  185  =1= 55 
1/64  11/25  44.0  345  .4-  72 
1/32  13/24  54.2  325  -4- 38 
1/16  24/29  82.7  325  4-  60 
1/8  22/24  91.7  628  4-  82 
1/4  19/19  100.0  790  4-  100 
Re,  transflantagon 7 Days after SRBC 
1/256  5/8  62.5  335  q- 40 
1/128  6/9  66.7  263  ±  43 
1/64  10/10  100.0  695  .4-  187 
1/32  7/7  100.0  424  4-  71 
0.25 
(0.19-0.31)§ 
* 107 thymocytes to primary recipients and  SRBC 18 hr later.  Portions of ceils lodging in 
spleens were retransplanted 4 or 7 days after SRBC. 
More than 100 direct PFC/spleen. One-half of all test spleen cells were plated. 
§ 95% confidence limits in parentheses. 
and a fixed number of marrow cells, it should have been possible to limit the number of ARC 
progeny cells involved in ASU formation. It was assumed that such cells were capable of reach- 
ing the test spleens and of interacting with maxrow P-PFC independently of each other. If so, 
the relationship between the number of retransplanted cells and the number of test spleens 
positive for PFC should conform to Poisson statistics. 
10 million thymocytes were injected into groups of irradiated mice to provide each recipient 
spleen with an average of 3 ARC. SRBC were given 18 hr later. 4 or 7 days after immunization, 
cells of primary spleens were pooled in suspension to average the number of ARC-derived cells 
per spleen equivalent. Graded fractions of one spleen equivalent of the suspension were mixed 
with 1.5 X  10  7 marrow cells for retransplantatiou with SRBC into test recipients. 
8-day  direct  plaque  responses  pooled  from  four  separate  experiments  are 
shown in Table V  and Fig. 2. 
As the retransplanted  fraction of 4  day spleens containing ARC-derived in- G.  M.  SHEARER  AND  G.  CUDKOWICZ  1253 
ducer cells increased from ~28 to ~, the proportion d  positive test spleens in- 
creased from 18.2 to 100 %. The observed frequencies of positive spleens plotted 
as a function of the fraction  of retransplanted  spleen  (log number  of inducer 
cells) fell within the predictions of the Poisson model. The probability value that 
1% of the cells of one primm3r spleen would yield positive test spleens for PFC 
was 0.25. This means that 0.04 (~5) of each primary 4 day spleen contained  1 
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Fxo. 2.  Percentage of spleens positive for direct PFC after injection of irradiated test mice 
with 1.5 X  107 marrow cells, 5 X  10  s SRBC, and graded fractions of spleens repopulated by 
3 thymic ARC (see the text). The number of test spleens assayed is given in Table V. Symbols 
indicate observed percentages, and the curve expected percentages according to the Poisson 
model. The fraction of retransplanted spleens for 63% positive test spleens contains an average 
of 1 detectable inducer unit and is indicated by the dotted llne. 
unit of ARC-derived inducer cells lodging in the test spleen on retransplantation 
and interacting with marrow P-PFC. Inasmuch as each primary spleen received 
3 ARC and presumably only 1-10% of the retransplanted cells were recovered 
(17-19), each ARC may have generated from 80 to 800 units of inducer cells in 
4 days. Assuming that no cells were lost from the spleens by migration, a mini- 
mum of 6-10 cell divisions could have occurred, with a doubling time of 10-16 hr. 
Expansion of the population of inducer cells continued beyond this time. 7 days 
after immunization,  ~66 of a primary spleen (instead of ~5  at 4 days) con- 
tained I unit of ARC-derived inducer cells (Table V, lower section). 1254  PROLIFERATION  OF  THYMIC  ARC 
Contrary to what had been noted before in one-step experiments  (10)  (Table 
IV), the mean number of PFC per test spleen varied in relation to the number of 
inducer cells regrafted and, hence,  to the percentage of positive spleens in the 
different groups. Whenever more than 63 %  of the mice in a group had positive 
spleens, the mean number of PFC was 3-5 multiples of 150, the mean number of 
PFC generated by 1 ASU (16). Presumably,  such spleens received several in- 
ducer cells, each of which interacted with 1 P-PFC to form several ASU. When- 
ever less than 63 % of the mice in a group had positive spleens, the mean number 
of PFC per positive spleen was smaller, and could have been generated by 1 or 
2 ASU. In these groups, spleens must have received either 1 or 2 inducer ceils, or 
TABLE VI 
Percentage of Po~i~e Spleens in BDF1 Test Recipient Mice after Infusion of 1.5 X  107 Marrow 
Cells, 5 X  lO  s SRBC, and Retransplanted Thymocytes Exposed to Vinblastine* 
Portion of primary  Fraction of positive  Percentage  of 12ositive  Mean No. of direct  PFC 
spleens retransplanted  spleens~  spleens~  per positive spleen -4- sE  with marrow 
Vinblastine 3.75 Days after SRBC 
1/16  9/13  69.3  375  -4- 45 
1/8  12/14  85.8  330  4- 59 
1/4  2/2  i00.0  910  4- 69O 
Vinblastine I Day after SRBC 
1/16  1/8  12.5  725 
1/8  2/10  20.0  300  +  10 
* 10 7 thymocytes to primary recipients and SRBC 18 hr later. Portions of cells lodging in 
spleens were retransplanted  4 days after SRBC and either 3 days or 7 hr after vinblastlne. 
Untreated  controls axe included in Table V. 
:~ More than loo direct PFC/spleen. One-haff of all test spleen cells were pIated. 
none. If so, individual inducer cells would have interacted with 1 P-PFC, while 
all the progeny of 1 ARC would have interacted  with several P-PFC,  as pre- 
viously shown (10). 
Effect of Vinblastine on Generation of Inducer Cells by ARC.- 
To test whether the increase of inducer cells was due to proliferation of ARC, 0.5  mg of 
vinblastin¢ sulfate  (Velban, Eli Lilly and Co., Indianapolis,  Ind.) dissolved in saline was in- 
jected into the peritoneum of irradiated  BDFx mice grafted with 107 thymocytes and SRBC. 
The drug specifically inhibits cells entering mitosis and has been used to study the proliferative 
state of ASU (23, 24). Vinblastine was given either 3 days or 7 hr before retransplantation  of 
thymus-derived cells of the primary spleens. This corresponded to 1 and 3.75 days after the 
first  exposure to antigen,  respectively. Graded fractions  of pooled spleens were mixed with 
1,5 X  107 marrow cells and injected into test recipients with SRBC. 
8-day PFC responses are shown in Table VI. G.  M.  SHEARER  AND  G.  CTj'DKOWICZ  1255 
Vinblastine did not reduce significantly the frequency or magnitude of PFC 
responses when given 3.75  days after stimulation of thymocytes with SRBC, 
i.e.  when production of inducer cells by proliferation of ARC could have al- 
ready occurred to a great extent. If most inducer cells were also proliferating, the 
time of exposure to vinblastine, although short (7 hr), should have been suffi- 
cient to arrest a measurable proportion of such cells, their estimated doubling 
time being 10-16 hr. Vinblastine possibly carried into the test recipients with re- 
transplanted spleen cells did not interfere with interaction between inducer cells 
and P-PFC. In contrast to the lack of effect at 3.75 days, vinblastine markedly 
reduced the frequency of PFC responses when given 1 day after stimulation of 
thymocytes by SRBC. One-eighth of such treated spleens was approximately 
equivalent to ~28 of untreated spleens with respect to inducing marrow P-PFC. 
It is likely, therefore, that the drug reduced formation of inducer cells by inhib- 
iting proliferation of ARC  that had just been stimulated and were  entering 
mitosis. 
DISCUSSION 
The finding of Claman et al. (1) that bone marrow and thymus cells act syn- 
ergistically in antibody formation against SRBC gave impetus to studies aimed 
at identifying (a) the events occurring during the lag phase of the response (2, 5, 
9)  and (b)  the sources of restrictions for synthesis of one molecular species  of 
antibody by individual immunocytes (10,  11,  16).  The experiments reported 
here have indicated that one of the first detectable events of the immune re- 
sponse after administration of antigen to repopulated mice is proliferation of 
thymic ARC.  This  was  demonstrated in  two-step  experiments by  exposing 
transferred thymocytes and marrow cells to SRBC in separate irradiated host 
mice, and by assessing antigen-dependent changes of their number and/or func- 
tion by retransplantation. Thyrnic ARC generated "inducer" cells capable of 
interacting with marrow precursors of immunocytes so as to render them fully 
immunocompetent. Under the same conditions, potentially competent marrow 
cells did not appear to gain a new function. This is to say that, in contrast to thy- 
mus, transferred mouse marrow did not contain antigen-reactive cells capable of 
initiating the response to SRBC. It was not excluded, however, that quantita- 
tive changes of marrow P-PFC had occurred prior to interaction with thymus- 
derived cells. 
These results and interpretations are consistent with, and extend, the pre- 
vious work of Davies et al. (2, 9) and of Mitchell and Miller (3, 5). A mitotic 
response by thymus-derived cells preceding one by marrow-derived cells was 
seen in spleens of repopulated mice 1-5 days after a single injection of SRBC 
(2, 9). Since the thymic origin of mitotic cells was recognized by chromosomal 
markers, and since ARC are a minute fraction of thymocytes (10), Davies et al. 
could not decide whether ARC proliferated in response to SRBC or other thymic 1256  I~OLIFENATION  OF  THYMIC  ARC 
cells not necessarily relevant for the development of the immune response. In 
fact, nonspecific thymus-dependent  proliferation has been observed in mesothe- 
lial cells of the omentum of mice injected with SRBC (25). In contrast, the 
experiments  reported here were designed to assess only the population of thy- 
mns-derived cells that interacts with marrow P-PFC. Mitchell and Miller have 
shown that an antibody response could be obtained by first reacting thymic cells 
with antigen and then with marrow cells and again with the same antigen (3, 5). 
Our experiments have indicated that thymic ARC first proliferate in response to 
SRBC to generate specific inducer cells, which then interact with marrow ceils. 
The next steps of the immune response detected by these experiments were 
the interaction of inducer cells with marrow precursors, and the production of 
PFC. These steps are rather complex and can only be studied in detail if the 
distinct events composing them become separable;  their occurrence required  a 
second administration of the same antigen complex employed for stimulation of 
ARC. Antigen could have facilitated the interaction between  specific inducer 
cells and P-PFC, or stimulated P-PFC to generate immunocytes once the inter- 
action had occurred, or both. If potentially immunocompetent cells possessed 
antibody-like receptors at their surface, as postulated by Rajewsky et al. (26), 
one would expect that antigenic determinants play an essential role in bringing 
together inducer ceils and P-PFC to form ASU. Laskov has shown that marrow 
cells of unprimed mice can attract SRBC and form rosettes in vitro (27). Miller 
and  Phillips  have suggested  that rosette-forming  cells possess receptors  for 
antigens and that some of them participate in production of immunocytes (28). 
However,  the reactivities  of marrow cells and of thymocytes with antigens of 
SRBC are of a different nature: marrow cells, but not thymocytes,  form rosettes 
(27), and cells of thymus, but not of marrow, generate specific inducer ceils. 
Do the findings of cell transfer experiments conducted under rather unusual 
conditions  provide information pertinent to the functioning of the intact im- 
mune system? It is reasonable to assume that each distinct event of the immune 
response which can be experimentally separated for analysis can also occur in 
the intact animal. However,  one has to be reminded that under experimental 
conditions,  cell functions could be expressed to a degree that is normally not 
required or not permitted by homeostatic controls. With these reservations,  we 
shall attempt to delineate the sequence of some cellular events during the pri- 
mary immune response to antigens of SRBC. 
Antigen-reactive  ceils of thymic origin and immunocyte  precursors of marrow 
origin are dispersed throughout the lymphoid system of adult mice. Since bac- 
teria of the intestinal flora and SRBC share some antigens (29), it is likely that 
ARC generate inducer cells under the influence of cross-reacting antigens prior 
to immunization of mice with SRBC. The injection of SRBC will be followed 
promptly by interaction of existing inducer cells with precursors  of immuno- 
cytes, and by sustained formation of new inducer ceils from stimulated ARC. G.  M.  SHEARER  AND  O.  CUDKOWICZ  1257 
The latter cells may be precommitted to react with one or a small number of 
antigenic determinants. If so,  antigen-dependent proliferation of ARC would 
lead to expansion of the "selected" population of ceils that will interact with 
marrow-derived ceils.  However,  there is no compelling evidence against the 
possibility that ARC are not restricted. In this case, their "instructed" progeny 
cells would have to undergo specificity differentiation for the antigen initiating 
the immune response. In fact, inducer cells are specific for antigen (Table II). 
This may be a  necessary condition either for their contact (directed by anti- 
gen ?) with specific marrow-derived P-PFC or for conferring specificity to un- 
committed precursors of immunocytes. An important consideration  is the number 
of cell divisions occurring after stimulation of ARC. In transfer experiments and 
in the absence of marrow cells, 6-10 divisions can occur in 4 days. It is likely, 
however, that under more usual circumstances interaction with marrow-derived 
cells removes inducer cells from the proliferating pool, thus limiting or arresting 
further expansion. One could anticipate that the number of generations in each 
ARC-derived  clone  is  variable  and  dependent  upon  the  concentration  of 
marrow-derived cells and of the latter's availability for interaction. Although 
ARC are known to descend from marrow progenitor cells under thymic influence 
(16, 30), it is not yet possible to say whether ARC differentiate or simply mature 
into inducer cells, or whether they can self-replicate. Each of these possibilities is 
presently being subjected to experimental test. 
The elementary units for immune responses result from interaction of inducer 
ceils of thymic origin with marrow-derived precursors  of immunocytes, and 
perhaps with other cell types (11, 31). All cells participating in the interaction 
constitute an antigen-sensitive unit which is monospecific, since it generates 
immunocytes restricted to a single molecular ciass and specificity of antibody 
(10-16). The information for class restriction of ASU resides in one of the mar- 
row-derived components  (11),  and  this may also be  the case for specificitY 
restriction. Restriction strongly suggests that 1 marrow-derived precursor cell 
becomes part of each ASU in combination with at least 1 inducer unit or eell. 
ASU thus formed are independent of each other (13)  and generate dusters of 
immunocytes detectable by focus assays (16). They are the units responsible for 
all-or-none responses in limiting dilution assays (10, 12, 13). The large number 
of inducer cells that ARC can generate accounts for multiple ASU formation by 
individual ARC  (10).  If these considerations are correct, the number of im- 
munocytes generated by each ASU should remain constant when different cell 
types limit the formation of ASU in cell transfer experiments. The number of 
direct PFC/ASU is approximately 150 when thymocytes or marrow cells are the 
limiting call types (16). In spleen cell suspensions of unprimed mice, ARC and/ 
or inducer cells are presumably in relative excess  over marrow P-PFC  (32). 
Individual splenic ASU also yield about 150 direct PFC. Available evidence 
would then suggest that one inducer cell interacts with one marrow precursor 1258  PROLn~ERATION  OF  THYMIC  ARC 
(and perhaps  another cell type) to form the elementary responding unit special- 
ized for antibody class and specificity. 
One would expect that dose-response curves for PFC produced by transferred 
spleen should be linear and have a slope of 1.0, since (a) the yield of direct PFC/ 
ASU is constant in marrow-thymus cell mixtures and in spleen cell suspensions 
(16), and (b) the number of splenic ASU is a linear function of the number of 
nucleated cells (12, 13, 15, 17, 33). Instead, it has been observed that such dose- 
response curves are biphasic, with a linear upper portion having a slope of 1.0, 
and a lower portion that is either nonlinear or having a slope greater than 1.0 
(19, 33, 34). To explain such observations, Groves et al. (34) proposed that each 
ARC may interact with a variable but finite number of marrow precursors, thus 
forming ASU differing with respect to their cellular composition. The number of 
PFC/ASU should then be variable and directly related to the number of P-PFC 
entering the interaction. As P-PFC may not saturate ARC in spleen cell suspen- 
sions until a critical P-PFC concentration has been reached, such a model could 
reproduce the biphasic dose-response curves. However, the model has little pre- 
dictive value, since it is inconsistent  with the following realities  and ignores 
other possibilities: the number of PFC/ASU is not variable (16); ARC undergo 
proliferation and perhaps differentiation into inducer cells prior to interaction; 
each of the 80-800 inducer cells derived from 1 ARC can form 1 ASU yielding 
the constant number of approximately 150  direct PFC~; graded numbers of 
inducer cells transferred with a nonlimiting constant number of marrow cells 
yield linear dose-response lines for direct PFC*; progeny cells of ARC can inter- 
act with precursors  of direct and indirect PFC, but each ASU is restricted to 
generate either direct or indirect PFC, but not both (10, 16); the lower portion 
of biphasic dose-response curves characteristic of transferred spleen cells can be 
accounted for by variable numbers of cell divisions  in ARC-derived clones 
rather than by multiple ARC interactions. 
SUMMARY 
Marrow cells and thymocytes of unprimed donor mice  were transplanted 
separately into X-irradiated syngeneic hosts,  with or without sheep  erythro- 
cytes (SRBC). Antigen-dependent changes in number or function of potentially 
immunocompetent cells were assessed by retransplantation of thymus-derived 
cells with fresh bone marrow cells and SRBC; of marrow-derived cells with fresh 
thymocytes and SRBC; and of thymus-derived with marrow-derived  cells and 
SRBC.  Plaque-forming  cells (PFC)  of the direct  (IgM)  and indirect  (IgG) 
classes were enumerated in spleens of secondary host mice at the time of peak 
responses. By using this two-step design, it was shown (a) that thymus, but not 
Shearer, G. M., T. Ito, and G. Cudkowicz. Distinct events in the immune response elicited 
by transferred marrow and thymic cells.  II. Maturation of thymic antigen-reactive cells into 
specific inducer cells.  Manuscript in preparation. G. M.  SHEARER AND G.  CUDKOWICZ  1259 
bone marrow, contained antigen-reactive cells (ARC) capable of initiating the 
immune response to SRBC (first step), and (b) that the same antigen complex 
that  activated thymic ARC  was required  for the  subsequent  interaction  be- 
tween thymus-derived and  marrow cells and/or  for PFC  production  (second 
step). 
Thymic ARC separated from marrow cells but exposed to SRBC proliferated 
and generated specific inducer cells. These were the cells that interacted with 
marrow precursors of PFC to form the elementary units for plaque responses to 
SRBC,  i.e.  the class- and specificity-restricted antigen-sensitive units.  It was 
estimated that each ARC generated 80-800 inducer cells in 4 days by way of a 
minimum of 6-10 cell divisions. On the basis of the available evidence, a simple 
model was outlined for cellular events in the immune response to SRBC. 
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